DOCSLIB.ORG

Journal of Dentistry 82 (2019) 91–97

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Journal of Dentistry 82 (2019) 91–97 Journal of Dentistry 82 (2019) 91–97 Contents lists available at ScienceDirect Journal of Dentistry journal homepage: www.elsevier.com/locate/jdent Short communication A potential therapeutic target for regulating osteoporosis via suppression of osteoclast differentiation T ⁎ ⁎ Qin Suna, Boran Zhanga, Wei Zhua, Wei Weia, Jingzhi Maa, , Franklin R. Tayb, a Department of Stomatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China b College of Graduate Studies, Augusta University, Augusta, GA, USA ARTICLE INFO ABSTRACT Keywords: Objectives: Osteoclast differentiation is regulated by transcriptional, post-transcriptional and post-translational microRNA mechanisms. Micro-ribonucleic acids (miRNAs) are 20–24 nucleotides long non-coding RNAs involved in post- Transcription factor MafB translational regulation of gene expressions during osteoclast differentiation. The objective of the present study Osteoclasts was to investigate the role played by the miRNA, miR-338-3p, in osteoclastogenesis. Osteoporosis Methods: Osteoclastogenesis was induced in murine RAW264.7 cells using M-CSF and RANKL. The differentiated Transfection cells were harvested at designated times for TRAP staining and detection of designated gene expressions. A synthetic miR-338-3p mimic or its inhibitor was transfected into RAW264.7 cells prior to the induction of os- teoclastogenesis. The effects of mimic or inhibitor on osteoclastogenesis were examined by qRT-PCR and TRAP staining. Bioinformatic analysis and luciferase activity were performed to identify the relationship between miR- 338-3p and the transcription factor MafB. The miR-338-3p mimic and MafB siRNA were co-transfected into RAW264.7 cells to evaluate the cross-talk between miR-338-3p and MafB. Results: miR-338-3p was increased significantly during osteoclast differentiation. Overexpression of miR-338-3p promoted osteoclastogenesis while its inhibition had the opposite effect. Bioinformatic analysis and dual luci- ferase assays indicated that miR-338-3p targeted MafB to repress its gene expression. MafB knockdown by RNA silencing blocked the promotional effect of miR-338-3p on osteoclast differentiation. Conclusion: Because miR-338-3p is crucial for osteoclastic differentiation via targeting of the transcription factor MafB, inhibition of this miRNA represents a potential strategy for modulating osteoporosis in an aging popu- lation. Clinical significance: Understanding the role played by miR-338-3p in osteoclast differentiation bridges the gap between the pathogenesis of osteoporosis and the quest for novel therapeutics to reduce the risk of bone fracture associated with this global disease. 1. Introduction human body, are multinucleated cells derived from hematopoietic stem cells or monocyte/macrophage progenitor cells [8]. Unlike lympho- Bone homeostasis is incumbent upon the orchestrated functions of cytes and macrophages that are destined to remove foreign bodies, osteocytes, osteoblasts and osteoclasts [1–3]. Metabolic bone disorders osteoclasts are involved in the destruction of host tissues. This activity such as osteoporosis, osteopenia and rheumatoid arthritis-related bone may be perceived as a physiologic auto-immune reaction in response to destruction occur when osteoclastic bone resorption exceeds osteo- the need for bone remodeling. Differentiation of osteoclasts from he- blastic bone formation. Unconstrained increase in bone catabolism re- matopoietic precursors is a complex, multi-step process [9] regulated sults in osteoporosis, a highly-morbid, globally-escalating systemic by a plethora of cytokines, growth factors and hormones, including skeletal disorder in which reduction in bone mineral density and micro- macrophage colony-stimulating factor (M-CSF), receptor activator of architectural deterioration of bone tissues increase the risk of bone nuclear factor kappa-B ligand (RANKL), sex hormones and parathyroid fragility and fracture [4]. Osteoporosis-related fractures increases the hormone [10,11]. Some of transcription factors involved in osteoclas- mortality rate of the elderly [5,6]. To date, no effective strategies are togenesis have been identified, such as V-maf musculoaponeurotic fi- available for preventing and treating this type of fracture [7]. brosarcoma oncogene homolog B (transcription factor MafB), nuclear Osteoclasts, the only cell type capable of bone resorption in the factor of activated T-cells cytoplasmic 1 (NFATc1) and microphthalmia- ⁎ Corresponding authors. E-mail addresses: [email protected] (J. Ma), [email protected] (F.R. Tay). https://doi.org/10.1016/j.jdent.2019.01.015 Received 25 December 2018; Received in revised form 20 January 2019; Accepted 23 January 2019 0300-5712/ Published by Elsevier Ltd. Q. Sun et al. Journal of Dentistry 82 (2019) 91–97 associated transcription factor (MitF) [12–14]. Nevertheless, the precise Valencia, CA, USA). The miScript SYBR Green PCR kit (Qiagen) was molecular mechanism of osteoclast differentiation remains obscure. used for analysis of miRNA expression. Small nuclear RNA (U6 snRNA) Micro-ribonucleic acids (miRNAs) are short, 20–24 nucleotides was used for miRNA normalisation. Primers for miRNA-338-3p and U6 long, endogenously non-coding small RNAs that act as post-transcrip- snRNA were purchased from Qiagen. A SYBR Green PCR kit (Takara, tional regulators of gene expression via binding to the 3′-untranslated Tokyo, Japan) was used for detection of mRNA expression. Primer se- region (UTR) of target mRNAs to repress their translation [15]. They quences for the genes examined are listed in Supplementary Table I. play important roles in cell differentiation, proliferation and self-re- Glyceraldehyde 3-phosphate dehydrogenase (GADPH) was used for newal by providing an epigenetic mechanism for modulating gene ex- normalisation of mRNA measurements. Experiments were conducted in pression in many homeostatic processes and pathological conditions triplicate. Gene expression ratios were presented as means and standard [16]. A variety of miRNAs are involved in osteoclast differentiation deviations based on the results of three independent measurements [17]. For example, miR-503 in CD14+ peripheral blood mononuclear from each experiment. Gene expression was calculated using the −ΔΔ cells regulate osteoclast formation by targeting RANK [18]. By targeting 2 CT method. NFATc1, miR-124 plays a significant role in regulating osteoclast dif- ferentiation [19]. The miRNA miR-34c promotes osteoclast differ- 2.3. Western blot entiation by targeting leucine-rich repeat-containing G-protein coupled receptor 4, which is associated with the signalling of nuclear factor After quantification with BCA Protein Assay Kit (Pierce Biotech, kappa-light-chain-enhancer of activated B cells (NF-κB) and glycogen Rockford, IL, USA), protein samples were analysed with sodium dodecyl synthase kinase 3-β [20]. sulfate polyacrylamide gel electrophoresis. Separated proteins were Although miRNAs are involved in bone remodelling and bone dis- transferred to nitrocellulose membranes (Roche Diagnostics GmbH, eases [21], only a few microRNAs are concomitantly involved in os- Mannheim, Germany). After blocking with 5% skim milk, protein- teogenesis and osteoclastogenesis [22]. To date, there is no information containing membranes were incubated with anti-MafB antibody indicating that a specific microRNA is involved in the balance between (1:1000; Abcam, Cambridge, MA) or anti-GADPH antibody (1:2000; osteoblast and osteoclast differentiation. For example, miR-21 and miR- Santa Cruz Biotechnology, Santa Cruz, CA) overnight at 4 °C and sec- 26a were found to modulate the activities of osteoblasts and osteoclasts ondary anti-rabbit horseradish peroxidase-conjugated antibody. [21]. Although miRNAs serve as biomarkers and potential therapeutic Antibody-antigen complexes were detected using chemiluminescent targets for diseases [23], clinical research on these aspects is still at its ECL reagent (Pierce Biotech, ThermoFisher Scientific, Waltham, MA, infancy. No specific microRNA has been identified as the most optimal USA). therapeutic target for osteoporosis [24]. The miRNA miR-338-3p functions as a negative regulator of osteoblast differentiation in bone 2.4. TRAP staining marrow stem cells via epigenetic modulation of its target genes Runt- related transcription factor-2 (Runx2) and fibroblast growth factor re- Staining was performed with an acid phosphatase kit ceptor-2 (Fgfr2)[25]. This miRNA potentially modulates osteoporosis (MilliporeSigma, St. Louis, MO, USA). The cultured cells were fixed in via its effect on osteoblasts [26]. Compared with normal tissues, miR- fixative solution for 30 s at ambient temperature. After rinsing and 338-3p expression increases significantly in osteosarcoma [27]. These addition of TRAP staining medium, the cells were incubated at 37 °C data suggest that miR-338-3p is involved in diseases of bone home- and protected from light for 1 h. Staining was performed in triplicate. ostasis. Accordingly, the present study tested the hypothesis that miR- Images of TRAP-positive multinuclear cells were recorded using an 338-3p suppresses the anabolic component of bone homeostasis by inverted phase-contrast microscope (IX41, Olympus, Japan). modulating a target transcription factor involved in osteoclastogenesis. Successful validation of this hypothesis paths the way for future re- 2.5. Modulation of miR-338-3p search on the use of miR-338-3p as a biomarker and therapeutic target in preventing osteoporosis. Transfection of
Load more

Recommended publications
  • Accompanies CD8 T Cell Effector Function Global DNA Methylation
    Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer, Benjamin G. Barwick, Benjamin A. Youngblood, Rafi Ahmed and Jeremy M. Boss This information is current as of October 1, 2021. J Immunol 2013; 191:3419-3429; Prepublished online 16 August 2013; doi: 10.4049/jimmunol.1301395 http://www.jimmunol.org/content/191/6/3419 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2013/08/20/jimmunol.130139 Material 5.DC1 References This article cites 81 articles, 25 of which you can access for free at: http://www.jimmunol.org/content/191/6/3419.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 1, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2013 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Global DNA Methylation Remodeling Accompanies CD8 T Cell Effector Function Christopher D. Scharer,* Benjamin G. Barwick,* Benjamin A. Youngblood,*,† Rafi Ahmed,*,† and Jeremy M.
    [Show full text]
  • Blimp1-Mediated Repression of Negative Regulators Is Required for Osteoclast Differentiation
    Blimp1-mediated repression of negative regulators is required for osteoclast differentiation Keizo Nishikawaa,b, Tomoki Nakashimaa,b,c, Mikihito Hayashia,b, Takanobu Fukunagaa,b, Shigeaki Katod,e, Tatsuhiko Kodamaf, Satoru Takahashig, Kathryn Calameh, and Hiroshi Takayanagia,b,c,1 aDepartment of Cell Signaling, Tokyo Medical and Dental University, Tokyo 113-8549, Japan; bGlobal Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo 113-8549, Japan; cTakayanagi Osteonetwork Project, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Tokyo 113-8549, Japan; dInstitute of Molecular and Cellular Biosciences, Graduate School of Medicine, University of Tokyo, Tokyo 113-0032, Japan; eKato Nuclear Complex, Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Saitama 332-0012, Japan; fResearch Center for Advanced Science and Technology, Department of Molecular Biology and Medicine, University of Tokyo, Tokyo 153-8904, Japan; gInstitute of Basic Medical Sciences and Laboratory Animal Resource Center, University of Tsukuba, Tsukuba 305-8575, Japan; and hDepartment of Biochemistry and Molecular Biophysics, Columbia University College of Physicians and Surgeons, New York, NY 10032 Edited by Anjana Rao, Harvard Medical School, Boston, MA, and approved December 23, 2009 (received for review November 7, 2009) Regulation of irreversible cell lineage commitment depends on a own promoter in cooperation with c-Fos (12). This autoampli-
    [Show full text]
  • Lhx2 Regulates Bone Remodeling in Mice by Modulating RANKL Signaling in Osteoclasts
    Cell Death and Differentiation (2014) 21, 1613–1621 & 2014 Macmillan Publishers Limited All rights reserved 1350-9047/14 www.nature.com/cdd Lhx2 regulates bone remodeling in mice by modulating RANKL signaling in osteoclasts JH Kim1,2,3, BU Youn1,2, K Kim1,2, JB Moon1,2, J Lee1,2, K-Il Nam4, Y-W Park5, DDM O’Leary6, KK Kim1,2,3 and N Kim*,1,2,3 The LIM homeobox 2 (Lhx2) transcription factor Lhx2 has a variety of functions, including neural induction, morphogenesis, and hematopoiesis. Here we show the involvement of Lhx2 in osteoclast differentiation. Lhx2 was strongly expressed in osteoclast precursor cells but its expression was significantly reduced during receptor activator of nuclear factor-jB ligand (RANKL)- mediated osteoclastogenesis. Overexpression of Lhx2 in bone marrow-derived monocyte/macrophage lineage cells (BMMs), which are osteoclast precursor cells, attenuated RANKL-induced osteoclast differentiation by inhibiting the induction of nuclear factor of activated T cells c1 (NFATc1). Interestingly, interaction of Lhx2 proteins with c-Fos attenuated the DNA-binding ability of c-Fos and thereby inhibited the transactivation of NFATc1. Furthermore, Lhx2 conditional knockout mice exhibited an osteoporotic bone phenotype, which was related with increased osteoclast formation in vivo. Taken together, our results suggest that Lhx2 acts as a negative regulator of osteoclast formation in vitro and in vivo. The anti-osteoclastogenic effect of Lhx2 may be useful for developing a therapeutic strategy for bone disease. Cell Death and Differentiation (2014) 21, 1613–1621; doi:10.1038/cdd.2014.71; published online 6 June 2014 Bone homeostasis is maintained by a delicate balance PU.1, and nuclear factor of activated T cells c1 (NFATc1), between the activities of osteoblasts and those of osteoclasts.
    [Show full text]
  • Gene Expression Profiling of Nfatc1-Knockdown In
    cells Article Gene Expression Profiling of NFATc1-Knockdown in RAW 264.7 Cells: An Alternative Pathway for Macrophage Differentiation Roberta Russo , Selene Mallia, Francesca Zito and Nadia Lampiasi * Institute of Biomedicine and Molecular Immunology “Alberto Monroy”, National Research Council, Via Ugo La Malfa 153, 90146 Palermo, Italy; [email protected] (R.R.); [email protected] (S.M.); [email protected] (F.Z.) * Correspondence: [email protected]; Tel.: +39-091-680-9513 Received: 13 December 2018; Accepted: 5 February 2019; Published: 7 February 2019 Abstract: NFATc1, which is ubiquitous in many cell types, is the master regulator of osteoclastogenesis. However, the molecular mechanisms by which NFATc1 drives its transcriptional program to produce osteoclasts from macrophages (M) remains poorly understood. We performed quantitative PCR (QPCR) arrays and bioinformatic analyses to discover new direct and indirect NFATc1 targets. The results revealed that NFATc1 significantly modified the expression of 55 genes in untransfected cells and 31 genes after NFATc1-knockdown (≥2). Among them, we focused on 19 common genes that showed changes in the PCR arrays between the two groups of cells. Gene Ontology (GO) demonstrated that genes related to cell differentiation and the development process were significantly (p > 0.05) affected by NFATc1-knockdown. Among all the genes analyzed, we focused on GATA2, which was up-regulated in NFATc1-knockdown cells, while its expression was reduced after NFATc1 rescue. Thus, we suggest GATA2 as a new target of NFATc1. Ingenuity Pathway Analysis (IPA) identified up-regulated GATA2 and the STAT family members as principal nodes involved in cell differentiation.
    [Show full text]
  • The Transcriptome of Utricle Hair Cell Regeneration in the Avian Inner Ear
    The Journal of Neuroscience, March 5, 2014 • 34(10):3523–3535 • 3523 Development/Plasticity/Repair The Transcriptome of Utricle Hair Cell Regeneration in the Avian Inner Ear Yuan-Chieh Ku,1 Nicole A. Renaud,1 Rose A. Veile,1 Cynthia Helms,1 Courtney C.J. Voelker,2 Mark E. Warchol,2 and Michael Lovett1 1Department of Genetics and 2Department of Otolaryngology, Washington University School of Medicine, St Louis, Missouri 63110 Sensory hair cell loss is the major cause of hearing and balance disorders. Mammals are incapable of sustained hair cell regeneration, but lower vertebrates can regenerate these mechano-electrical transducers. We present the first comprehensive transcriptome (by mRNA- Seq) of hair cell regeneration in the chick utricle. We provide pathway and pattern annotations and correlate these with the phenotypic events that occur during regeneration. These patterns are surprisingly synchronous and highly punctuated. We show how these patterns are a new resource for identifying components of the hair cell transcriptome and identify 494 new putative hair-cell-specific genes and validate three of these (of three tested) by immunohistochemical staining. We describe many surprising new components and dynamic expression patterns, particularly within NOTCH signaling. For example, we show that HES7 is specifically expressed during utricle hair cell regeneration and closely parallels the expression of HES5. Likewise, the expression of ATOH1 is closely correlated with HEYL and the HLH inhibitory transcription factors ID1, ID2, and ID4.
    [Show full text]
  • Xo PANEL DNA GENE LIST
    xO PANEL DNA GENE LIST ~1700 gene comprehensive cancer panel enriched for clinically actionable genes with additional biologically relevant genes (at 400 -500x average coverage on tumor) Genes A-C Genes D-F Genes G-I Genes J-L AATK ATAD2B BTG1 CDH7 CREM DACH1 EPHA1 FES G6PC3 HGF IL18RAP JADE1 LMO1 ABCA1 ATF1 BTG2 CDK1 CRHR1 DACH2 EPHA2 FEV G6PD HIF1A IL1R1 JAK1 LMO2 ABCB1 ATM BTG3 CDK10 CRK DAXX EPHA3 FGF1 GAB1 HIF1AN IL1R2 JAK2 LMO7 ABCB11 ATR BTK CDK11A CRKL DBH EPHA4 FGF10 GAB2 HIST1H1E IL1RAP JAK3 LMTK2 ABCB4 ATRX BTRC CDK11B CRLF2 DCC EPHA5 FGF11 GABPA HIST1H3B IL20RA JARID2 LMTK3 ABCC1 AURKA BUB1 CDK12 CRTC1 DCUN1D1 EPHA6 FGF12 GALNT12 HIST1H4E IL20RB JAZF1 LPHN2 ABCC2 AURKB BUB1B CDK13 CRTC2 DCUN1D2 EPHA7 FGF13 GATA1 HLA-A IL21R JMJD1C LPHN3 ABCG1 AURKC BUB3 CDK14 CRTC3 DDB2 EPHA8 FGF14 GATA2 HLA-B IL22RA1 JMJD4 LPP ABCG2 AXIN1 C11orf30 CDK15 CSF1 DDIT3 EPHB1 FGF16 GATA3 HLF IL22RA2 JMJD6 LRP1B ABI1 AXIN2 CACNA1C CDK16 CSF1R DDR1 EPHB2 FGF17 GATA5 HLTF IL23R JMJD7 LRP5 ABL1 AXL CACNA1S CDK17 CSF2RA DDR2 EPHB3 FGF18 GATA6 HMGA1 IL2RA JMJD8 LRP6 ABL2 B2M CACNB2 CDK18 CSF2RB DDX3X EPHB4 FGF19 GDNF HMGA2 IL2RB JUN LRRK2 ACE BABAM1 CADM2 CDK19 CSF3R DDX5 EPHB6 FGF2 GFI1 HMGCR IL2RG JUNB LSM1 ACSL6 BACH1 CALR CDK2 CSK DDX6 EPOR FGF20 GFI1B HNF1A IL3 JUND LTK ACTA2 BACH2 CAMTA1 CDK20 CSNK1D DEK ERBB2 FGF21 GFRA4 HNF1B IL3RA JUP LYL1 ACTC1 BAG4 CAPRIN2 CDK3 CSNK1E DHFR ERBB3 FGF22 GGCX HNRNPA3 IL4R KAT2A LYN ACVR1 BAI3 CARD10 CDK4 CTCF DHH ERBB4 FGF23 GHR HOXA10 IL5RA KAT2B LZTR1 ACVR1B BAP1 CARD11 CDK5 CTCFL DIAPH1 ERCC1 FGF3 GID4 HOXA11
    [Show full text]
  • Nfatc1 As a Therapeutic Target in Burkitt's Lymphoma
    NFATc1 as a Therapeutic Target in Burkitt’s Lymphoma NFATc1 – ein Angriffspunkt zur Therapie des Burkitt-Lymphoms Aus dem Institut für Pathologie der Universität Würzburg Vorstand: Prof. Dr. Andreas Rosenwald Dissertation zur Erlangung der Doktorwürde der Medizinischen Fakultät der Julius-Maximilians-Universität Würzburg vorgelegt von Hendrik Eike Fender Geboren am 6.8.1988 in Göttingen Würzburg, Mai 2015 Referent: Prof. Dr. Dr. Edgar Serfling Korreferent: Prof. Dr. Max Topp Berichterstatter: Prof. Dr. Ralf Bargou Dekan: Prof. Dr. Matthias Frosch Tag der mündlichen Prüfung: 27.4.2016 Der Promovend ist Arzt Abbreviations α anti AICD activation induced cell death AID activation-induced deaminase ATR Ataxia telangiectasia and Rad3 related ATRA all-trans retinoic acid BAFF B cell activation factor of the TNF family BCL6 B-cell lymphoma 6 BCR B cell receptor bHLH basic helix-loop-helix BL Burkitt’s lymphoma BLNK B cell linker Protein Btk Bruton’s tyrosine kinase cAMP cyclic adenosine monophosphate CD cluster of Differentiation CDK cyclin-dependent kinase CK1 α casein kinase 1α CN calcineurin CRAC calcium-release activated calcium CsA cyclosporin A CSR class switch recombination DLBCL diffuse large B cell lymphomas EBV Epstein-Barr-Virus EGTA ethylene glycol tetraacetic acid GC germinal center GM-CSF granulocyte-macrophage colony stimulating factor GSK-3 glycogen synthase kinase 3 Ig immunoglobulin IL interleukin IP3 inositol trisphosphate ITAM immunoreceptor Tyrosine-based Activation Motifs JAK3 Janus kinase 3 mTOR mammalian Target of Rapamycin
    [Show full text]
  • Mafb Negatively Regulates RANKL-Mediated Osteoclast Differentiation
    HEMATOPOIESIS MafB negatively regulates RANKL-mediated osteoclast differentiation Kabsun Kim,1 Jung Ha Kim,1 Junwon Lee,1 Hye Mi Jin,1 Hyun Kook,1 Kyung Keun Kim,1 Soo Young Lee,2 and Nacksung Kim1 1Research Institute of Medical Sciences and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju, Korea; 2Division of Molecular Life Sciences and Center for Cell Signaling Research, Ewha Womans University, Seoul, Korea Receptor activator of nuclear factor ␬B phage lineage cells (BMMs) inhibits the transactivation of NFATc1 and OSCAR. Fur- ligand (RANKL) induces osteoclast forma- formation of TRAP؉ multinuclear osteo- thermore, reduced expression of MafB by tion from hematopoietic cells via regula- clasts, but phagocytic activity of BMMs is RNAi enhances osteoclastogenesis and tion of various transcription factors. Here, retained. Furthermore, overexpression of increases expression of NFATc1 and we show that MafB negatively regulates MafB in BMMs attenuates the gene induc- OSCAR. Taken together, our results sug- 2020 31 August on guest by https://ashpublications.org/blood/article-pdf/109/8/3253/1291252/zh800807003253.pdf from Downloaded RANKL-induced osteoclast differentia- tion of NFATc1 and osteoclast-associated gest that MafB can act as an important tion. Expression levels of MafB are signifi- receptor (OSCAR) during RANKL-mediated modulator of RANKL-mediated osteoclas- cantly reduced by RANKL during osteo- osteoclastogenesis. In addition, MafB pro- togenesis. (Blood. 2007;109:3253-3259) clastogenesis. Overexpression of MafB teins interfere with the DNA-binding ability in bone marrow-derived monocyte/macro- of c-Fos, Mitf, and NFATc1, inhibiting their © 2007 by The American Society of Hematology Introduction Bone is continuously remodeled by 2 specialized cells: osteoblasts In addition, NFATc1 synergistically induces OSCAR gene expres- and osteoclasts.
    [Show full text]
  • Human Venous Valve Disease Caused by Mutations in FOXC2 and GJC2
    Published Online: 19 July, 2017 | Supp Info: http://doi.org/10.1084/jem.20160875 Downloaded from jem.rupress.org on September 24, 2018 Article Human venous valve disease caused by mutations in FOXC2 and GJC2 Oliver Lyons,1 Prakash Saha,1 Christopher Seet,1 Adam Kuchta,3 Andrew Arnold,3 Steven Grover,4,5 Victoria Rashbrook,1 Amélie Sabine,6,7 Gema Vizcay-Barrena,2 Ash Patel,1 Francesca Ludwinski,1 Soundrie Padayachee,3 Tsutomu Kume,8 Brenda R. Kwak,9 Glen Brice,10 Sahar Mansour,10 Pia Ostergaard,11 Peter Mortimer,11 Steve Jeffery,11 Nigel Brown,12 Taija Makinen,13 Tatiana V. Petrova,6,7 Bijan Modarai,1 and Alberto Smith1 1Academic Department of Vascular Surgery, Cardiovascular Division, BHF Centre of Research Excellence, King’s College London, St Thomas’ Hospital, London, England, UK 2Center for Ultrastructural Imaging, King’s College London, London, England, UK 3Department of Ultrasonic Angiology, Guy’s and St Thomas’ NHS Foundation Trust, London, England, UK 4Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Boston, MA 5Harvard Medical School, Boston, MA 6Department of Fundamental Oncology, Ludwig Institute for Cancer Research, Zurich, Switzerland 7Division of Experimental Pathology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Epalinges, Switzerland 8Feinberg Cardiovascular Research Institute, Northwestern University School of Medicine, Evanston, IL 9Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland 10South West Thames Regional Genetics Service, 11Cardiovascular and Cell Sciences Institute, and 12Institute of Medical and Biomedical Education, St George’s Hospital, London, England, UK 13Rudbeck Laboratory, Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden Venous valves (VVs) prevent venous hypertension and ulceration.
    [Show full text]
  • Identification of Potential Core Genes in Sevoflurance Induced Myocardial
    Identication of Potential core genes in Sevourance induced Myocardial Energy Metabolism in Patients Undergoing Off-pump Coronary Artery Bypass Graft Surgery using Bioinformatics analysis Hua Lin ( [email protected] ) Tianjin Medical University General Hospital Airport Site Research article Keywords: sevourane, Myocardial Energy Metabolism, Off-pump Coronary Artery Bypass Graft Surgery Posted Date: November 18th, 2019 DOI: https://doi.org/10.21203/rs.2.17434/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/15 Abstract Background: Myocardial ischemia-reperfusion injury always happened after Off-pump coronary artery bypass graft(OPCABG), and this can not be avoided altogether. In this study, we tried to detect potential genes of sevourane-induced myocardial energy metabolism in patients undergoing OPCABG using bioinformatics analysis. Methods: We download and analyze the gene expression prole data from the Gene Expression Omnibus(GEO) database using bioinformatics methods. We downloded the gene expression data from the Gene Expression Omnibus(GEO) database using bioinformatics methods. Gene Ontology(GO) functional annotation analysis and Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway enrichment analysis were used to analysis the screened differentially expressed genes(DEGs). Then, we established a protein–protein interaction (PPI) network to nd hub genes associated with myocardial energy metabolism. Results: Through PPI network, we nd ten hub genes, including JUN, EGR1, ATF3, FOSB, JUNB, DUSP1, EGR2, NR4A1, BTG2, NR4A2. Conclusions: In conclusion, the proteins encoded by EGR1ATF3c-FosBtg2JunBDUSP1NR4A1BTG2 and NR4A2 were related to cardiac function. ATF3, FOSB, JUNB, DUSP1, NR4A1, NR4A2 are related to apoptosis of cardiomyocytes. The protein encoded by BTG2 is related to hypertrophy.
    [Show full text]
  • Signaling Networks That Control the Lineage Commitment and Differentiation of Bone Cells
    Critical Reviews™ in Eukaryotic Gene Expression, 19(1):1–46 (2009) Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells Carrie S. Soltanoff,1 Wei Chen,1,2 Shuying Yang,1,2 & Yi-Ping Li1,2,* 1Department of Cytokine Biology, The Forsyth Institute, Boston, MA 02115, USA; 2Department of Developmental Biology, Harvard School of Dental Medicine, Boston, MA 02115, USA * Address all correspondence to Yi-Ping Li, PhD, Department of Cytokine Biology, The Forsyth Institute, 140 The Fenway, Boston, MA 02115; Tel: 617- 892-8260; Fax: 617-262-4021; [email protected] ABSTRACT: Osteoblasts and osteoclasts are the two major bone cells involved in the bone remodeling process. Osteoblasts are responsible for bone formation while osteoclasts are the bone-resorbing cells. The major event that triggers osteogenesis and bone remodeling is the transition of mesenchymal stem cells into differentiating osteoblast cells and monocyte/macrophage precursors into differentiating osteoclasts. Imbalance in differentiation and func- tion of these two cell types will result in skeletal diseases such as osteoporosis, Paget’s disease, rheumatoid arthritis, osteopetrosis, periodontal disease, and bone cancer metastases. Osteoblast and osteoclast commitment and differ- entiation are controlled by complex activities involving signal transduction and transcriptional regulation of gene expression. Recent advances in molecular and genetic studies using gene targeting in mice enable a better understanding of the multiple factors and signaling
    [Show full text]
  • NFAT Signaling and Bone Homeostasis
    & Throm gy b o o l e o t m Journal of Hematology & a b o m Chen and Pan, J Hematol Thromb Dis 2013, 1:1 l e i c H D f DOI: 10.4172/2329-8790.1000102 o i s l e a Thromboembolic Diseases ISSN: 2329-8790 a n s r e u s o J Review Article Open Access NFAT Signaling and Bone Homeostasis Chen S1 and Pan M2* 1Department of Oncology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, P.R. China 2Department of Medical Oncology and Hematology, Kaiser Permanente Medical Center, Santa Clara, CA, USA Abstract Bone homeostasis is a function of the constant balancing acts between osteoclasts and osteoblasts, regulated by numerous factors in cellular and molecular levels. Calcineurin-NFAT pathway plays critical roles in bone homeostasis by regulating many aspects of bone development and remodeling. NFATc1 is the master transcription factor of osteoclasts, acting downstream of RANKL (receptor activator of nuclear factor-κB ligand) to control osteoclastogenesis. NFATc1 also plays important role in osteoblastogenesis, its increased nuclear occupancy in osteoblasts causes osteopetrosis by regulating chemokine and Wnt pathways. Targeting NFAT pathway may provide therapeutic avenues for treating bony disorders. Keywords: Osteoclastogenesis; NFAT; Calcineurin; Osteoblastogen- produce both M-CSF and RANKL to regulate osteoclasts. A single base esis pair insertion of M-CSF receptor gene Csfm in mice is the cause of the recessive mutation osteopetrosis (op) [3]. In human, an activating Regulation of Osteoclasts and Osteoblasts by Key mutation of rank gene and a deactivating mutation of opg (encoded Molecular Networks for osteoprotegerin, OPG) gene cause familiar expansile osteolysis and Paget’s disease of bones [4].
    [Show full text]